Sabaa International Company for Pharmaceutical and Chemical Industry (CASE: SIPC)
Health Care · Pharmaceuticals · EG
EGP5.13
-0.77% today · +82.6% 1Y
Sabaa International Company for Pharmaceutical and Chemical Industry (CASE: SIPC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.50M.
Over the last twelve months the share price has gained 82.6%, trading between 2.62 and 7.28.
Tweenvest scores Sabaa International Company for Pharmaceutical and Chemical Industry across four factors: quality 63/100, value 15/100, growth 62/100. Its strongest factor is quality.
SIPC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.50M
- Revenue (TTM)
- $851.97K
- P/E
- —
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- EGP7.28
- 52-week low
- EGP2.62
- Avg volume (3M)
- —
- Shares outstanding
- 250.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Emyria LimitedASX: EMD | $25.23M | AU$0.05 | -10.00% |
| Biofrontera AGXTRA: B8FK | $25.17M | €3.68 | +5.75% |
| Gennex Laboratories LimitedBSE: 531739 | $24.73M | Rs9.80 | -2.97% |
| Yung Zip Chemical Ind. Co., Ltd.TPEX: 4102 | $24.54M | NT$18.45 | -0.27% |
| iAnthus Capital Holdings, Inc.CNSX: IAN | $24.46M | CA$0.01 | -50.00% |
| PT Indofarma TbkIDX: INAF | $23.91M | Rp— | — |
| TherapeuticsMD, Inc.NasdaqGS: TXMD | $23.73M | $2.01 | -1.95% |
| Kontafarma China Holdings LimitedSEHK: 1312 | $23.50M | HK$0.03 | +3.13% |
Figures last refreshed Oct 4, 2026.